新一代测序法检测非小细胞肺癌中表皮生长因子受体突变的分布数据

Q4 Medicine Journal of Oncological Sciences Pub Date : 2021-01-01 DOI:10.37047/jos.2021-84407

İ. Gökmen, E. Taştekin, A. Gökyer, Sezin Sayın, I. Çiçin

{"title":"新一代测序法检测非小细胞肺癌中表皮生长因子受体突变的分布数据","authors":"İ. Gökmen, E. Taştekin, A. Gökyer, Sezin Sayın, I. Çiçin","doi":"10.37047/jos.2021-84407","DOIUrl":null,"url":null,"abstract":"diagnosis and treatment, the incidence of lung cancer remains high both in Turkey and worldwide, and it is one of the leading causes of cancer-related deaths.1 When we evaluate Turkey, according to the age-standardized cancer rate in males, lung cancer occupies first place with 57.7%, and in females, it is at fifth place with 9.8%. 80% of lung cancer cases are nonsmall cell lung cancer (NSCLC), most of them are diagnosed at an advanced stage, and only 19% of patients can live for five years or longer.2 The dominant histological subtype in NSCLC is adenocarcinoma both in the world and in Turkey (47.1%).3","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Distribution Data of Epidermal Growth Factor Receptor Mutations Detected by Next-Generation Sequencing Method in Non-Small Cell Lung Cancer\",\"authors\":\"İ. Gökmen, E. Taştekin, A. Gökyer, Sezin Sayın, I. Çiçin\",\"doi\":\"10.37047/jos.2021-84407\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"diagnosis and treatment, the incidence of lung cancer remains high both in Turkey and worldwide, and it is one of the leading causes of cancer-related deaths.1 When we evaluate Turkey, according to the age-standardized cancer rate in males, lung cancer occupies first place with 57.7%, and in females, it is at fifth place with 9.8%. 80% of lung cancer cases are nonsmall cell lung cancer (NSCLC), most of them are diagnosed at an advanced stage, and only 19% of patients can live for five years or longer.2 The dominant histological subtype in NSCLC is adenocarcinoma both in the world and in Turkey (47.1%).3\",\"PeriodicalId\":31838,\"journal\":{\"name\":\"Journal of Oncological Sciences\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Oncological Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37047/jos.2021-84407\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oncological Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37047/jos.2021-84407","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

在诊断和治疗方面，肺癌的发病率在土耳其和世界范围内仍然很高，是癌症相关死亡的主要原因之一当我们对土耳其进行评估时，根据男性年龄标准化癌症发病率，肺癌以57.7%居首位，女性以9.8%居第五位。80%的肺癌病例为非小细胞肺癌(NSCLC)，大多数是在晚期诊断出来的，只有19%的患者可以存活5年或更长时间在世界和土耳其，非小细胞肺癌的主要组织学亚型是腺癌(47.1%)

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Distribution Data of Epidermal Growth Factor Receptor Mutations Detected by Next-Generation Sequencing Method in Non-Small Cell Lung Cancer

diagnosis and treatment, the incidence of lung cancer remains high both in Turkey and worldwide, and it is one of the leading causes of cancer-related deaths.1 When we evaluate Turkey, according to the age-standardized cancer rate in males, lung cancer occupies first place with 57.7%, and in females, it is at fifth place with 9.8%. 80% of lung cancer cases are nonsmall cell lung cancer (NSCLC), most of them are diagnosed at an advanced stage, and only 19% of patients can live for five years or longer.2 The dominant histological subtype in NSCLC is adenocarcinoma both in the world and in Turkey (47.1%).3

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊